The psychobiology of using automated driving systems: A systematic review and integrative model.

Automated car Automated mobility Autonomous driving Autonomous mobility Autonomous vehicle Reporting guideline

Journal

Psychoneuroendocrinology
ISSN: 1873-3360
Titre abrégé: Psychoneuroendocrinology
Pays: England
ID NLM: 7612148

Informations de publication

Date de publication:
07 2019
Historique:
received: 13 07 2018
revised: 10 09 2018
accepted: 18 09 2018
pubmed: 7 10 2018
medline: 6 5 2020
entrez: 7 10 2018
Statut: ppublish

Résumé

Using vehicles with engaged automated driving systems (ADS) ('highly automated driving', HAD) will substantially impact on future society's mobility, yet the current understanding of human psychobiology related to HAD is still limited. Hence, we synthesized evidence on the psychobiology of subjects using HAD, informing an integrative model of the psychobiology of HAD, and providing guidance for reporting future research on this topic. We included (non-)randomized studies assessing human peripheral biology markers of in-vehicle-users in real or simulated driving environments, using vehicles with vs. without engaged ADS, published in English until April 2018. We systematically searched Web of Science, SCOPUS, and PubMed. The search consisted of a combination of terms describing HAD and psychobiological parameters. Risk of bias was assessed regarding randomization, blinding, incomplete outcome data, selective outcome reporting, and other potential causes. We extracted data using predefined data fields. Four out of five studies included in this review (N = 194 subjects) reported associations of use of vehicles with vs. without engaged ADS with various psychobiological parameters, including heart rate, respiratory sinus arrhythmia (RSA), indicators of electrodermal activity (EDA), and masseter electromyography (EMG). Heart rate tended to be reduced during HAD along with increased EDA and EMG, with no clear indication for changes in RSA. We cannot exclude substantial risk of bias, among others because the status of engagement of ADS was mostly non-randomized. Yet, findings suggest that HAD goes along with tractable changes in peripheral biology. Informed by the conceptual endophenotype approach (Hellhammer et al., 2018, Psychoneuroendocrinology), we propose the Embodied Driving (EMBODD) model that describes how HAD reshapes vehicle use experience, and highlight how to make future ADS equipped vehicles successful regarding user's health. Based on the review, we suggest reporting guidelines for future research on the psychobiology of HAD.

Identifiants

pubmed: 30290968
pii: S0306-4530(18)30587-0
doi: 10.1016/j.psyneuen.2018.09.029
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

51-63

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Gunther Meinlschmidt (G)

Division of Clinical Psychology and Cognitive Behavioral Therapy, International Psychoanalytic University, Stromstrasse 1, D-10555 Berlin, Germany; Department of Psychosomatic Medicine, Faculty of Medicine, University of Basel and University Hospital Basel, Hebelstrasse 2, CH-4031 Basel, Switzerland; Division of Clinical Psychology and Epidemiology, Department of Psychology, University of Basel, Missionsstrasse 60/62, CH-4055 Basel, Switzerland. Electronic address: gunther.meinlschmidt@unibas.ch.

Esther Stalujanis (E)

Division of Clinical Psychology and Cognitive Behavioral Therapy, International Psychoanalytic University, Stromstrasse 1, D-10555 Berlin, Germany; Division of Clinical Psychology and Psychiatry, Department of Psychology, University of Basel, Missionsstrasse 60/62, CH-4055 Basel, Switzerland.

Marion Tegethoff (M)

Division of Clinical Psychology and Psychiatry, Department of Psychology, University of Basel, Missionsstrasse 60/62, CH-4055 Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH